Latest News

Around the Helix: Cell and Gene Therapy Company Updates – July 23, 2025
Around the Helix: Cell and Gene Therapy Company Updates – July 23, 2025

July 23rd 2025

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Jeffrey Chamberlain, PhD, Professor, Neurology and Medical Genetics, and Adjunct Professor, Biochemistry, and McCaw Endowed Chair of Muscular Dystrophy at University of Washington
Jeffrey Chamberlain, PhD, on the Future of Duchenne Muscular Dystrophy Gene Therapy

July 23rd 2025

Sarepta Voluntarily Pauses All Shipments of DMD Gene Therapy Elevidys Several Days After Informal Request From FDA
Sarepta Voluntarily Pauses All Shipments of DMD Gene Therapy Elevidys Several Days After Informal Request From FDA

July 22nd 2025

UCSF Tests Lentiviral Vector-Based Gene Therapy for Artemis-Deficient SCID in Phase 1/2 Trial
UCSF Tests Lentiviral Vector-Based Gene Therapy for Artemis-Deficient SCID in Phase 1/2 Trial

July 21st 2025

Video Interviews

Conference Coverage

View All
Nathan Yozwiak, PhD, the head of research at the Gene and Cell Therapy Institute at Mass General Brigham
Fostering Collaboration in Cell and Gene Therapy Research

July 16th 2025

Nathan Yozwiak, PhD, the head of research at the GCTI
Nathan Yozwiak, PhD, on Fostering Collaboration in Cell and Gene Therapy Research

July 15th 2025

Kilian Guse, PhD, the vice president of genetic medicine platforms at Pacira
High-Capacity Adenovirus Vectors for Gene Therapy

July 14th 2025

Derek Jackson, BS, MA, the vice president of cell & gene therapy product development at Pacira
Evaluating Gene Therapy PCRX-201 for Osteoarthritis of the Knee

July 13th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.